Neurogene Inc.
NGNE · XNASCIK 1404644fmd_0MSK1GNZMS5DA42VDF4TP44AYEManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2006 to Sep 30, 2026, 62 periods
AI-written
A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.
Loading